ANTONAZZO IPPAZIO COSIMO

Antonazzo, I., Rozza, D., Cortesi, P., Fornari, C., Zanzottera Ferrari, E., Paris, C., et al. (2025). Generalizability and treatment with sodium-glucose co-trasporter-2 inhibitors (SGLT2i) among patients with type 2 diabetes: an assessment using an Italian primary care database. ACTA DIABETOLOGICA, 62(3), 343-351 [10.1007/s00592-024-02359-1]. Dettaglio

Ferrara, P., Monti, C., Rozza, D., Fornari, C., Antonazzo, I., Ferrara, M., et al. (2025). Incidence and risk factors for falls among nursing home residents in Italy: a retrospective cohort study. AGING CLINICAL AND EXPERIMENTAL RESEARCH, 37(1) [10.1007/s40520-025-03111-7]. Dettaglio

Brauer, M., Roth, G., Aravkin, A., Zheng, P., Abate, K., Abate, Y., et al. (2024). Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. THE LANCET, 403(10440 (18–24 May 2024)), 2162-2203 [10.1016/s0140-6736(24)00933-4]. Dettaglio

Fornari, A., Antonazzo, I., Rocino, A., Preti, D., Fragomeno, A., Cucuzza, F., et al. (2024). The psychosocial impact of haemophilia from patients’ and caregivers’ point of view: The results of an Italian survey. HAEMOPHILIA, 30(2), 449-462 [10.1111/hae.14926]. Dettaglio

Antonazzo, I., Cortesi, P., Zanon, E., Pasca, S., Morfini, M., Santoro, C., et al. (2024). Personalized Prophylaxis with myPKFiTCE: A Real-World Cost-Effectiveness Analysis in Haemophilia A Patients. MEDICINA, 60(1) [10.3390/medicina60010034]. Dettaglio